Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e68c308335a29450b99a9fb44fd7145e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0012 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2013-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8478b03ca681ebbdbfef57b95cdd6f68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705fe04fbee2fae3cc7feef63142a579 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52280a7f2a78567ca254d7d779f6dbd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4c2cd9a4812f13940471a6eb551d6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63812d06863c14db4361b78ab54c26d |
publicationDate |
2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014086944-A1 |
titleOfInvention |
DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a) |
abstract |
The present invention provides an agent for the treatment or prophylaxis of arteriosclerosis comprising an expression vector encoding a chimeric Hepatitis B virus core antigen polypeptide inserted with an amino acid sequence containing a specific epitope of apolipoprotein (a), wherein the amino acid sequence containing the specific epitope is inserted between the amino acid residues 80 and 81 of the hepatitis B virus core antigen polypeptide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695420-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9446120-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9913886-B2 |
priorityDate |
2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |